上市公司資料
 
深圳市海普瑞藥業集團股份有限公司 股票代號:  09989
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO., LTD. 集團網址: http://www.hepalink.com
資產
  2024/12
RMB(K$)
變動 2023/12
RMB(K$)
2022/12
RMB(K$)
固定資產2,853,9220.173%2,849,0042,699,288
攤佔聯營公司及共同控制公司權益350,320-65.109%1,004,046989,386
其他資產4,518,008-4.806%4,746,0984,655,045
流動資產9,621,274-9.270%10,604,26912,472,311
    庫存現金及銀行結存1,421,827-19.473%1,765,6451,319,707
    存貨5,393,947-18.938%6,654,1116,843,906
    其他流動資產2,805,50028.427%2,184,5134,308,698
總資產17,343,524-9.685%19,203,41720,816,030
負債
  2024/12
RMB(K$)
變動 2023/12
RMB(K$)
2022/12
RMB(K$)
流動負債3,699,237-25.810%4,986,1825,575,796
長期負債1,442,166-35.296%2,228,8582,830,769
總負債5,141,403-28.740%7,215,0408,406,565
主要財務比率
  2024/12
RMB(K$)
變動 2023/12
RMB(K$)
2022/12
RMB(K$)
流動比率(x)2.601--2.1272.237
長期負債/股東資金比率(%)11.871%--18.709%22.991%
總負債/股東資金比率(%)42.321%--60.564%68.275%

 

Copyright © 2025 ET Net Limited. All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.